Deadline looms for businesses to submit comments to FDA on CBD

420Patients.com is accepting qualified medical marijuana patients and caregivers to join our network. We value every registered member and we hope to serve you in Arizona. This article brought to you by 420 community friends mmjbusinessdaily.com

Producers and retailers of CBD products have a few more days to try to discourage international health regulators from classifying the substance as a psychotropic drug.

The U.S. Food and Drug Administration announced last month it wants comments about CBD to send to the World Health Organization. The deadline for comments has been extended a week to midnight ET Sept. 20.

The FDA plans to forward the comments to the WHO without recommending an action.

Deadline looms for businesses to submit comments to FDA on CBD is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Leave a Reply

Skip to toolbar